Login / Signup

Protocolized screening and detection of occult alcohol use before and after liver transplant: Lessons learned from a quality improvement initiative.

Nicholas LimThomas M LeventhalMary J ThomsonM HassanJ ThompsonA AdamsSrinath ChinnakotlaV HumphrevilleRaja KandaswamyVarvara A KirchnerTimothy L PruettL SchullerM McCartyJohn R Lake
Published in: Clinical transplantation (2023)
When screening for ETOH use in pre- and post-LT patients, protocol adherence is higher using PEth compared to EtG. While protocolized biomarker screening can detect recurrent ETOH use in this population, engagement of patients into chemical dependency treatment remains challenging.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • insulin resistance
  • quality improvement
  • real time pcr
  • combination therapy